Vimarsana
Biggest News Aggregation in the World

Page 7 - Markl Baum News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Markl Baum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Markl Baum Today - Breaking & Trending Today

B. Riley Leads Financing to Support Harrow Health Acquisition - Vimarsana News

B. Riley Leads Financing to Support Harrow Health Acquisition

LOS ANGELES, March 28, 2023 /PRNewswire/ -- B. Riley Financial, Inc. , a diversified financial services platform, today announced that certain of its affiliates led the financing to support Harrow... | March 28, 2023

B. Riley Leads Financing to Support Harrow Health Acquisition - Vimarsana News

B. Riley Leads Financing to Support Harrow Health Acquisition

/PRNewswire/ -- B. Riley Financial, Inc. (NASDAQ: RILY) ("B. Riley"), a diversified financial services platform, today announced that certain of its affiliates...

Harrow Health, Inc. (NASDAQ:HROW) Q4 2022 Earnings Call Transcript - Vimarsana News

Harrow Health, Inc. (NASDAQ:HROW) Q4 2022 Earnings Call Transcript

Operator: Good afternoon. And welcome to Harrow's Q4 2022 Earnings Conference Call. My name is MJ, and I will be your operator for today's call.

Harrow Health Inc forges agreement to acquire exclusive US rights to blockbuster Novartis AG eyecare drugs - Vimarsana News

Harrow Health Inc forges agreement to acquire exclusive US rights to blockbuster Novartis AG eyecare drugs

Harrow Health Inc (NASDAQ:HROW) revealed that it has forged a binding agreement for the acquisition of the exclusive US commercial rights to five Food and...

Harrow Sells Non-Ophthalmic Compounding Business - Vimarsana News

Harrow Sells Non-Ophthalmic Compounding Business

NASHVILLE, Tenn.--(BUSINESS WIRE)--$HROW--Harrow (Nasdaq: HROW), an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative ophthalmic therapies, today announced the sale of its non‑ophthalmic compounding business to Innovation Compounding Pharmacy, LLC,...